Why 340B and limited distribution arrangements are both pricing and compliance problems
Specialty pharmacies participating in the 340B Drug Pricing Program and those operating within limited distribution drug networks face requirements that are simultaneously financial and regulatory. Pricing has to reflect the correct tier for each transaction, and the system has to produce documentation that would satisfy a program audit.
Standard pharmacy pricing configurations, built around a single price list with discount tiers, do not capture the complexity of 340B eligibility determination or limited distribution allocation rules. Organizations that try to manage this manually alongside a standard NetSuite pricing setup create both pricing errors and compliance exposure.
How 340B pricing tiers need to be configured
340B pricing depends on covered entity eligibility, which can vary by patient encounter, prescriber, and location within a health system. The item and pricing configuration needs to support multiple concurrent price tiers per item, selected based on the specific transaction's eligibility determination, not a single static 340B price applied uniformly.
This typically requires integration between the eligibility determination system, often a third-party 340B split billing software, and NetSuite, so that the correct acquisition cost and pricing tier are reflected in the transaction record automatically rather than through manual price overrides.
Duplicate discount prevention
One of the core compliance obligations in the 340B program is preventing duplicate discounts, ensuring that a unit of drug does not receive both a 340B discount and a Medicaid rebate. This requires transaction-level tracking that flags Medicaid-eligible transactions and excludes them from 340B replenishment, or correctly manages the accumulator and carve-in or carve-out designation for the covered entity.
This is not something NetSuite handles natively out of the box; it requires configuration or integration with 340B-specific compliance software, with the resulting eligibility flag captured on the transaction record so that finance and compliance both have a single source of truth for audit purposes.
Limited distribution drug network accounting
Specialty pharmacies designated within a limited distribution network for a specific therapy operate under contractual allocation rules that govern how much product they can dispense, often tied to a manufacturer-defined allocation or patient enrollment cap. Financially, this requires tracking allocation utilization against contractual limits, and revenue recognition tied to the specific contract terms of the limited distribution agreement, which frequently differ from standard specialty pharmacy dispensing revenue recognition.
Configuring item and customer records to reflect the specific limited distribution agreement terms, including allocation caps and reporting obligations back to the manufacturer, keeps the pharmacy within contractual bounds and produces the utilization reporting manufacturers typically require.
Contract and rebate accounting across covered entities
Specialty pharmacies operating across multiple 340B covered entities and commercial payer contracts need rebate and contract accounting that can segment performance by entity and by contract. A blended view obscures which relationships are performing and which are eroding margin through unfavorable pricing or high rebate exposure.
This requires the chart of accounts and customer or entity hierarchy in NetSuite to mirror the actual contractual relationships, not a simplified customer list that treats every covered entity the same way.
Audit readiness for both programs
340B program audits and manufacturer limited distribution network audits both require the pharmacy to produce transaction-level evidence supporting pricing determinations, eligibility flags, and allocation compliance. A NetSuite environment configured with these requirements in mind can produce this evidence directly from the transaction record.
A NetSuite environment configured without this in mind requires manual reconstruction from multiple systems every time an audit request arrives, an exercise that consumes weeks of finance and compliance time and increases the risk of an incomplete or inconsistent response.